A causal role for uric acid in fructose-induced metabolic syndrome

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 3, 2006, Pages

  Nakagawa, Takahiko ^a   Hu, Hanbo ^a   Zharikov, Sergey ^a   Tuttle, Katherine R ^b   Short, Robert A ^b   Glushakova, Olena ^a   Ouyang, Xiaosen ^a   Feig, Daniel I ^c   Block, Edward R ^a   Herrera Acosta, Jaime ^d   Patel, Jawaharlal M ^a   Johnson, Richard J ^a,e  

^a UNIVERSITY OF FLORIDA   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^e TAP Pharmaceuticals   (United States)

Author keywords

Insulin resistance; Obesity

Indexed keywords

ACETYLCHOLINE; ALLOPURINOL; BENZBROMARONE; FRUCTOSE; GLUCOSE; NITRIC OXIDE; URIC ACID; URICOSURIC AGENT; XANTHINE OXIDASE INHIBITOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIETARY INTAKE; DRUG ACTIVITY; DRUG EFFECT; FEEDING BEHAVIOR; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SYSTOLIC HYPERTENSION; URIC ACID BLOOD LEVEL; VASODILATATION; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; SPRAGUE DAWLEY RAT;

ANIMALS; FRUCTOSE; MALE; METABOLIC SYNDROME X; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; URIC ACID;

EID: 33645560926     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00140.2005     Document Type: Article

References (42)

1. Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Milionis HJ, and Mikhailidis DP. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) study. Am J Kidney Dis 43: 589-599, 2004.
2. Berkowitz D. Gout, hyperlipidemia, and diabetes interrelationships. JAMA 197: 77-80, 1966.
3. Bray GA, Nielsen SJ, and Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537-543, 2004.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
5. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, and Scherrer U. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133: 360-363, 2003.
6. Dandona P, Aljada A, Chaudhuri A, Mohanty P, and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454, 2005.
7. Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep 3: 289-292, 2003.
8. Dennison BA, Rockwell HL, and Baker SL. Excess fruit juice consumption by preschool-aged children is associated with short stature and obesity. Pediatrics 99: 15-22, 1997.
9. Facchini F, Chen YD, Hollenbeck CB, and Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266: 3008-3011, 1991.
10. Ferris TF and Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med 44: 359-365, 1968.
11. Ford ES, Giles WH, and Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449, 2004.
12. Gresser U, Gathof BS, and Gross M. Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome? Adv Exp Med Biol 370: 87-90, 1994.
13. Hallfrisch J. Metabolic effects of dietary fructose. FASEB J 4: 2652-2660, 1990.
14. Hallfrisch J, Ellwood K, Michaelis OE Reiser S, and Prather ES. Plasma fructose, uric acid, and inorganic phosphorus responses of hyperinsulinemic men fed fructose. J Am Coll Nutr 5: 61-68, 1986.
15. Hwang IS, Ho H, Hoffman BB, and Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.
16. Iwatani M, Wasada T, Katsumori K, Watanabe-Takahashi C, Kamatani N, and Iwamoto Y. Troglitazone decreases serum uric acid concentrations in type II diabetic patients and non-diabetics. Diabetologia 43: 814-815, 2000.
17. Johnson RJ, Titte S, Cade JR, Rideout BA, and Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol 25: 3-8, 2005.
18. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, and Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 67: 1739-1742, 2005.
19. Knittle JL and Ahrens EH Jr. Carbohydrate metabolism in two forms of hyperglyceridemia. J Clin Invest 43: 485-495, 1964.
20. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, and Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
21. Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, and Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens 21: 1563-1574, 2003.
22. Ludwig DS, Peterson KE, and Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357: 505-508, 2001.
23. Masuo K, Kawaguchi H, Mikami H, Ogihara T, and Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42: 474-480, 2003.
24. Matsuda M and DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999.
25. Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, and Matsuzawa Y. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47: 929-933, 1998.
26. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, and Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 93: 817-821, 1980.
27. Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, and Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 148: 635-640, 2004.
28. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, and Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200, 2001.
29. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, and Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530, 2003.
30. Parks EJ and Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 71: 412-433, 2000.
31. Prichard BN, Owens CW, and Woolf AS. Adverse reactions to diuretics. Eur Heart J 13, Suppl G: 96-103, 1992.
32. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
33. Roy D, Perreault M, and Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endocrinol Metab 274: E692-E699, 1998.
34. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, and Herrera-Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110, 2002.
35. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, and Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292: 927-934, 2004.
36. - imbalance in insulin-resistant rat aorta. Diabetes 48: 2437-2445, 1999.
37. Smith CM, Rovamo LM, and Raivio KO. Fructose-induced adenine nucleotide catabolism in isolated rat hepatocytes. Can J Biochem 55: 1237-1240, 1977.
38. Stirpe F, Della Corte E, Bonetti E, Abbondanza A, Abbati A, and De Stefano F. Fructose-induced hyperuricaemia. Lancet 2: 1310-1311, 1970.
39. Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, and Karumanchi SA. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension 43: 988-992, 2004.
40. Tsunoda S, Kamide K, Minami J, and Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens 15: 697-701, 2002.
41. Vuorinen-Markkola H and Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78: 25-29, 1994.
42. Wexler BC and Greenberg BP. Effect of increased serum urate levels on virgin rats with no arteriosclerosis versus breeder rats with preexistent arteriosclerosis. Metabolism 26: 1309-1320, 1977.